Mechanical control of cardiac myofibroblasts

Journal of Molecular and Cellular Cardiology

Volumn 93, Issue , 2016, Pages 133-142

  van Putten, Sander ^a   Shafieyan, Yousef ^a   Hinz, Boris ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Extracellular matrix; Fibroblast; Fibrosis; Integrin; Mechanical stress; Scar; Stiffness; TGF 1; Smooth muscle actin

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; BIOLOGICAL MARKER;

CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL STRESS; CELL TRANSPORT; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CYTOKINE RESPONSE; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; HEART MUSCLE CELL; HUMAN; MECHANOSENSING; MECHANOTRANSDUCTION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET CELL; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CYTOLOGY; FIBROSIS; MECHANICAL STRESS; MECHANICS; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CYTOKINES; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; MECHANICAL PHENOMENA; MECHANOTRANSDUCTION, CELLULAR; MYOCARDIUM; MYOCYTES, CARDIAC; MYOFIBROBLASTS; PHENOTYPE; STRESS, MECHANICAL;

EID: 84949639933     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.025     Document Type: Review

References (214)

1. Dixon I.M.C., Cunnington R.H., Rattan S.G., Wigle J.T. Cardiac fibrosis and heart failure-cause or effect?. Cardiac Fibrosis and Heart Failure: Cause or Effect? 2015, 1-4. Springer International Publishing. I.M.C.D., J.T. Wigle (Eds.).
2. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456(7224):980-984.
3. Vasquez C., Benamer N., Morley G.E. The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. J. Cardiovasc. Pharmacol. 2011, 57(4):380-388.
4. Rosker C., Salvarani N., Schmutz S., Grand T., Rohr S. Abolishing myofibroblast arrhythmogeneicity by pharmacological ablation of alpha-smooth muscle actin containing stress fibers. Circ. Res. 2011, 109(10):1120-1131.
5. Kakkar R., Lee R.T. Intramyocardial fibroblast myocyte communication. Circ. Res. 2010, 106(1):47-57.
6. Thompson S.A., Copeland C.R., Reich D.H., Tung L. Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers. Circulation 2011, 123(19):2083-2093.
7. Rohr S. Arrhythmogenic implications of fibroblast-myocyte interactions. Circ. Arrhythm. Electrophysiol. 2012, 5(2):442-452.
8. Mezzano V., Sheikh F. Cell-cell junction remodeling in the heart: possible role in cardiac conduction system function and arrhythmias?. Life Sci. 2012, 90(9-10):313-321.
9. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010, 106(11):1675-1680.
10. Harvey P.A., Leinwand L.A. The cell biology of disease: cellular mechanisms of cardiomyopathy. J. Cell Biol. 2011, 194(3):355-365.
11. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 2005, 45:657-687.
12. Ouzounian M., Lee D.S., Liu P.P. Diastolic heart failure: mechanisms and controversies. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5(7):375-386.
13. Martin M.L., Blaxall B.C. Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?. J. Cardiovasc. Transl. Res. 2012, 5(6):768-782.
14. Creemers E.E., Pinto Y.M. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 2011, 89(2):265-272.
15. Hinz B., Phan S.H., Thannickal V.J., Prunotto M., Desmouliere A., Varga J., et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180(4):1340-1355.
16. van den Borne S.W., Diez J., Blankesteijn W.M., Verjans J., Hofstra L., Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 2010, 7(1):30-37.
17. Turner N.A., Porter K.E. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 2013, 6(1):5.
18. Weber K.T., Sun Y., Bhattacharya S.K., Ahokas R.A., Gerling I.C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 2013, 10(1):15-26.
19. Schuetze K.B., McKinsey T.A., Long C.S. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. J. Mol. Cell. Cardiol. 2014, 70:100-107.
20. Baum J., Duffy H.S. Fibroblasts and myofibroblasts: what are we talking about?. J. Cardiovasc. Pharmacol. 2011, 57(4):376-379.
21. Lyon R.C., Zanella F., Omens J.H., Sheikh F. Mechanotransduction in cardiac hypertrophy and failure. Circ. Res. 2015, 116(8):1462-1476.
22. Davis J., Molkentin J.D. Myofibroblasts: trust your heart and let fate decide. J. Mol. Cell. Cardiol. 2014, 70:9-18.
23. Cartledge J.E., Kane C., Dias P., Tesfom M., Clarke L., McKee B., et al. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovasc. Res. 2015, 105(3):260-270.
24. Souders C.A., Bowers S.L.K., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circ. Res. 2009, 105(12):1164-1176.
25. Maillet M., van Berlo J.H., Molkentin J.D. Molecular basis of physiological heart growth: fundamental concepts and new players. Nat. Rev. Mol. Cell Biol. 2013, 14(1):38-48.
26. Kohl P., Gourdie R.G. Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue?. J. Mol. Cell. Cardiol. 2014, 70:37-46.
27. Mezzano V., Pellman J., Sheikh F. Cell junctions in the specialized conduction system of the heart. Cell Commun. Adhes. 2014, 21(3):149-159.
28. Micallef L., Vedrenne N., Billet F., Coulomb B., Darby I.A., Desmouliere A. The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair 2012, 5(Suppl. 1):S5. (Proceedings of Fibroproliferative disorders: from biochemical analysis to targeted therapiesPetro E Petrides and David Brenner).
29. Fan D., Takawale A., Lee J., Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012, 5(1):15.
30. Lajiness J.D., Conway S.J. Origin, development, and differentiation of cardiac fibroblasts. J. Mol. Cell. Cardiol. 2014, 70:2-8.
31. Deb A., Ubil E. Cardiac fibroblast in development and wound healing. J. Mol. Cell. Cardiol. 2014, 70C:47-55.
32. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123(2):255-278.
33. Squires C.E., Escobar G.P., Payne J.F., Leonardi R.A., Goshorn D.K., Sheats N.J., et al. Altered fibroblast function following myocardial infarction. J. Mol. Cell. Cardiol. 2005, 39(4):699-707.
34. Kramann R., Schneider R.K., DiRocco D.P., Machado F., Fleig S., Bondzie P.A., et al. Perivascular gli1(+) progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015, 16(1):51-66.
35. von Gise A., Pu W.T. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ. Res. 2012, 110(12):1628-1645.
36. Zeisberg E.M., Kalluri R. Origins of cardiac fibroblasts. Circ. Res. 2010, 107(11):1304-1312.
37. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13(8):952-961.
38. Lei P.P., Qu Y.Q., Shuai Q., Tao S.M., Bao Y.X., Wang Y., et al. Fibrocytes are associated with the fibrosis of coronary heart disease. Pathol. Res. Pract. 2013, 209(1):36-43.
39. Keeley E.C., Mehrad B., Strieter R.M. The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair 2011, 4:2.
40. Mollmann H., Nef H.M., Kostin S., von Kalle C., Pilz I., Weber M., et al. Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc. Res. 2006, 71(4):661-671.
41. Haudek S.B., Xia Y., Huebener P., Lee J.M., Carlson S., Crawford J.R., et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(48):18284-18289.
42. van Amerongen M.J., Bou-Gharios G., Popa E., van Ark J., Petersen A.H., van Dam G.M., et al. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J. Pathol. 2008, 214(3):377-386.
43. Chu P.Y., Mariani J., Finch S., McMullen J.R., Sadoshima J., Marshall T., et al. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am. J. Pathol. 2010, 176(4):1735-1742.
44. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 2010, 225(3):631-637.
45. Zimina E., Hinz B. The stressful life of cardiac myofibroblasts. Mechanisms of Cardiac Fibrosis and Heart Failure 2015, 71-92. Springer Science and Business Media Publishing. I.D., J. Weigel (Eds.).
46. Gabbiani G., Ryan G.B., Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27(5):549-550.
47. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3(5):349-363.
48. Hinz B. Formation and function of the myofibroblast during tissue repair. J. Investig. Dermatol. 2007, 127(3):526-537.
49. Chen C., Li R., Ross R.S., Manso A.M. Integrins and integrin-related proteins in cardiac fibrosis. J. Mol. Cell. Cardiol. 2015.
50. Schroer A.K., Merryman W.D. Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease. J. Cell Sci. 2015, 128(10):1865-1875.
51. Dugina V., Fontao L., Chaponnier C., Vasiliev J., Gabbiani G. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J. Cell Sci. 2001, 114(Pt 18):3285-3296.
52. Goffin J.M., Pittet P., Csucs G., Lussi J.W., Meister J.J., Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J. Cell Biol. 2006, 172(2):259-268.
53. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 2001, 12(9):2730-2741.
54. Desmoulière A., Badid C., Bochaton-Piallat M.L., Gabbiani G. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int. J. Biochem. Cell Biol. 1997, 29(1):19-30.
55. Kisseleva T., Cong M., Paik Y., Scholten D., Jiang C., Benner C., et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(24):9448-9453.
56. Hecker L., Jagirdar R., Jin T., Thannickal V.J. Reversible differentiation of myofibroblasts by MyoD. Exp. Cell Res. 2011, 317(13):1914-1921.
57. Yang X., Chen B., Liu T., Chen X. Reversal of myofibroblast differentiation: a review. Eur. J. Pharmacol. 2014, 734:83-90.
58. Driesen R.B., Nagaraju C.K., Abi-Char J., Coenen T., Lijnen P.J., Fagard R.H., et al. Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc. Res. 2014, 101(3):411-422.
59. Talele N.P., Fradette J., Davies J.E., Kapus A., Hinz B. Expression of alpha-smooth muscle actin determines the fate of mesenchymal stromal cells. Stem Cell Rep. 2015, 4(6):1016-1030.
60. Arnoldi R., Chaponnier C., Gabbiani G., Hinz B. Heterogeneity of smooth muscle. Muscle: Fundamental Biology and Mechanisms of Disease 2012, 1183-1195. Elsevier Inc. J. Hill (Ed.).
61. Henderson N.C., Arnold T.D., Katamura Y., Giacomini M.M., Rodriguez J.D., McCarty J.H., et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat. Med. 2013, 19(12):1617-1624.
62. Mederacke I., Hsu C.C., Troeger J.S., Huebener P., Mu X., Dapito D.H., et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 2013, 4:2823.
63. Duffield J.S. Cellular and molecular mechanisms in kidney fibrosis. J. Clin. Invest. 2014, 124(6):2299-2306.
64. Olson L.E., Soriano P. Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev. Cell 2009, 16(2):303-313.
65. Chong J.J., Reinecke H., Iwata M., Torok-Storb B., Stempien-Otero A., Murry C.E. Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev. 2013, 22(13):1932-1943.
66. Zhao W., Zhao T., Huang V., Chen Y., Ahokas R.A., Sun Y. Platelet-derived growth factor involvement in myocardial remodeling following infarction. J. Mol. Cell. Cardiol. 2011, 51(5):830-838.
67. Ieronimakis N., Hays A.L., Janebodin K., Mahoney W.M., Duffield J.S., Majesky M.W., et al. Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFbeta1 signaling in the mdx mouse model of Duchenne muscular dystrophy. J. Mol. Cell. Cardiol. 2013, 63:122-134.
68. Takeda N., Manabe I., Uchino Y., Eguchi K., Matsumoto S., Nishimura S., et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Invest. 2010, 120(1):254-265.
69. Acharya A., Baek S.T., Huang G., Eskiocak B., Goetsch S., Sung C.Y., et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139(12):2139-2149.
70. Song K., Nam Y.J., Luo X., Qi X., Tan W., Huang G.N., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485(7400):599-604.
71. Braitsch C.M., Kanisicak O., van Berlo J.H., Molkentin J.D., Yutzey K.E. Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J. Mol. Cell. Cardiol. 2013, 65:108-119.
72. Biernacka A., Dobaczewski M., Frangogiannis N.G. TGF-beta signaling in fibrosis. Growth Factors 2011, 29(5):196-202.
73. Dobaczewski M., Chen W., Frangogiannis N.G. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 2011, 51(4):600-606.
74. Hale T.M. Persistent phenotypic shift in cardiac fibroblasts: impact of transient renin angiotensin system inhibition. J. Mol. Cell. Cardiol. 2016, 93:125-132.
75. Rossi G.P., Cavallin M., Nussdorfer G.G., Pessina A.C. The endothelin-aldosterone axis and cardiovascular diseases. J. Cardiovasc. Pharmacol. 2001, 38(Suppl. 2):S49-S52.
76. Daskalopoulos E.P., Janssen B.J., Blankesteijn W.M. Targeting Wnt signaling to improve wound healing after myocardial infarction. Methods Mol. Biol. 2013, 1037:355-380.
77. Rønnov-Jessen L., Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Investig. 1993, 68(6):696-707.
78. Khouw I.M., van Wachem P.B., Plantinga J.A., Vujaskovic Z., Wissink M.J., de Leij L.F., et al. TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro. Biomaterials 1999, 20(19):1815-1822.
79. Akasaka Y., Ono I., Tominaga A., Ishikawa Y., Ito K., Suzuki T., et al. Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of alpha-smooth muscle actin, leading to reduction of wound contraction. Wound Repair Regen. 2007, 15(3):378-389.
80. Cushing M.C., Mariner P.D., Liao J.T., Sims E.A., Anseth K.S. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J. 2008, 22(6):1769-1777.
81. Heldin C.H. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun. Signal. 2013, 11:97.
82. Kong P., Christia P., Frangogiannis N.G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 2014, 71(4):549-574.
83. Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004, 15(4):255-273.
84. Iwayama T., Olson L.E. Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities. Curr. Rheumatol. Rep. 2013, 15(2):304.
85. Chen J.H., Chen W.L., Sider K.L., Yip C.Y., Simmons C.A. beta-catenin mediates mechanically regulated, transforming growth factor-beta1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler. Thromb. Vasc. Biol. 2011, 31(3):590-597.
86. Freedman B.R., Bade N.D., Riggin C.N., Zhang S., Haines P.G., Ong K.L., et al. The (dys)functional extracellular matrix. Biochim. Biophys. Acta 2015, 1853(11 Pt B):3153-3164.
87. Rienks M., Papageorgiou A. Novel regulators of cardiac inflammation: Matricellular proteins expand their repertoire. J. Mol. Cell. Cardiol. 2016, 91:172-178.
88. Howard C.M., Baudino T.A. Dynamic cell-cell and cell-ECM interactions in the heart. J. Mol. Cell. Cardiol. 2014, 70:19-26.
89. Goldsmith E.C., Bradshaw A.D., Zile M.R., Spinale F.G. Myocardial fibroblast-matrix interactions and potential therapeutic targets. J. Mol. Cell. Cardiol. 2014, 70:92-99.
90. Fomovsky G.M., Thomopoulos S., Holmes J.W. Contribution of extracellular matrix to the mechanical properties of the heart. J. Mol. Cell. Cardiol. 2010, 48(3):490-496.
91. Horn M.A., Trafford A.W. Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling. J. Mol. Cell. Cardiol. 2016, 93:175-185.
92. Bowers S.L., Banerjee I., Baudino T.A. The extracellular matrix: at the center of it all. J. Mol. Cell. Cardiol. 2010, 48(3):474-482.
93. McCulloch C.A., Coelho N.M. Collagen processing and its role in fibrosis. Cardiac Fibrosis and Heart Failure: Cause or Effect? 2015, 261-278. Springer International Publishing. I.M.C.D., J.T. Wigle (Eds.).
94. Wen Q., Janmey P.A. Effects of non-linearity on cell-ECM interactions. Exp. Cell Res. 2013, 319(16):2481-2489.
95. Klingberg F., Chow M.L., Koehler A., Boo S., Buscemi L., Quinn T.M., et al. Prestress in the extracellular matrix sensitizes latent TGF-beta1 for activation. J. Cell Biol. 2014, 207(2):283-297.
96. Yong K.W., Li Y., Huang G., Lu T.J., Safwani W.K., Pingguan-Murphy B., et al. Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy. Am. J. Physiol. Heart Circ. Physiol. 2015, 309(4):H532-H542.
97. MacKenna D., Summerour S.R., Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc. Res. 2000, 46(2):257-263.
98. Janmey P.A., Georges P.C., Hvidt S. Basic rheology for biologists. Methods Cell Biol. 2007, 83:3-27.
99. Wells R.G., Discher D.E. Matrix elasticity, cytoskeletal tension, and TGF-β: the insoluble and soluble meet. Sci. Signal. 2008, 1:pe13.
100. Engler A.J., Carag-Krieger C., Johnson C.P., Raab M., Tang H.Y., Speicher D.W., et al. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J. Cell Sci. 2008, 121(Pt 22):3794-3802.
101. Berry M.F., Engler A.J., Woo Y.J., Pirolli T.J., Bish L.T., Jayasankar V., et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. Heart Circ. Physiol. 2006, 290(6):H2196-H2203.
102. Majkut S., Idema T., Swift J., Krieger C., Liu A., Discher D.E. Heart-specific stiffening in early embryos parallels matrix and myosin expression to optimize beating. Curr. Biol. 2013, 23(23):2434-2439.
103. Ribeiro A.J., Ang Y.S., Fu J.D., Rivas R.N., Mohamed T.M., Higgs G.C., et al. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness. Proc. Natl. Acad. Sci. U. S. A. 2015, 112(41):12705-12710.
104. Dasbiswas K., Majkut S., Discher D.E., Safran S.A. Substrate stiffness-modulated registry phase correlations in cardiomyocytes map structural order to coherent beating. Nat. Commun. 2015, 6:6085.
105. Qiu Y., Bayomy A.F., Gomez M.V., Bauer M., Du P., Yang Y., et al. A role for matrix stiffness in the regulation of cardiac side population cell function. Am. J. Physiol. Heart Circ. Physiol. 2015, 308(9):H990-H997.
106. Shafieyan Y., Hinz B. Signs of stress on soft surfaces : a commentary on: Cui, Y., F.M. Hameed, B. Yang, K. Lee, C.Q. Pan, S. Park, and M. Sheetz. 2015. Cyclic stretching of soft substrates induces spreading and growth. Nat commun. 6:6333. J. Cell Commun. Signal. 2015.
107. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J. Biomech. 2010, 43(1):146-155.
108. Mendler N., Schuchhardt S., Sebening F. Measurement of intramyocardial oxygen tension during cardiac surgery in man. Res. Exp. Med. 1973, 159(3):231-238.
109. Schuchhardt S., Mendler N., Sebening F. Semilocal measurement of oxygen pressure in human myocardium. Pflugers Arch. Eur. J. Physiol. 1972, 332(Suppl. 332):R345.
110. Carreau A., Hafny-Rahbi B.E., Matejuk A., Grillon C., Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J. Cell. Mol. Med. 2011, 15(6):1239-1253.
111. Schenkman K.A. Cardiac performance as a function of intracellular oxygen tension in buffer-perfused hearts. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(6):H2463-H2472.
112. Mik E.G., Johannes T., Zuurbier C.J., Heinen A., Houben-Weerts J.H.P.M., Balestra G.M., et al. In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique. Biophys. J. 2008, 95(8):3977-3990.
113. Danielpour D., Kim K.Y., Dart L.L., Watanabe S., Roberts A.B., Sporn M.B. Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids. Growth Factors 1989, 2(1):61-71.
114. Oida T., Weiner H.L. Depletion of TGF-beta from fetal bovine serum. J. Immunol. Methods 2010, 362(1-2):195-198.
115. Ejiri H., Nomura T., Hasegawa M., Tatsumi C., Imai M., Sakakibara S., et al. Use of synthetic serum-free medium for culture of human dermal fibroblasts to establish an experimental system similar to living dermis. Cytotechnology 2015, 67(3):507-514.
116. Hinz B., Dugina V., Ballestrem C., Wehrle-Haller B., Chaponnier C. Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol. Biol. Cell 2003, 14(6):2508-2519.
117. Modarressi A., Pietramaggiori G., Godbout C., Vigato E., Pittet B., Hinz B. Hypoxia impairs skin myofibroblast differentiation and function. J. Investig. Dermatol. 2010, 130(12):2818-2827.
118. Pelham R.J., Wang Y. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(25):13661-13665.
119. Brown X.Q., Ookawa K., Wong J.Y. Evaluation of polydimethylsiloxane scaffolds with physiologically-relevant elastic moduli: interplay of substrate mechanics and surface chemistry effects on vascular smooth muscle cell response. Biomaterials 2005, 26(16):3123-3129.
120. Zajaczkowski M.B., Cukierman E., Galbraith C.G., Yamada K.M. Cell-matrix adhesions on poly(vinyl alcohol) hydrogels. Tissue Eng. 2003, 9(3):525-533.
121. Gilbert P.M., Havenstrite K.L., Magnusson K.E.G., Sacco A., Leonardi N.A., Kraft P., et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 2010, 329(5995):1078-1081.
122. Yeung T., Georges P.C., Flanagan L.A., Marg B., Ortiz M., Funaki M., et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskeleton 2005, 60(1):24-34.
123. Liu F., Lagares D., Choi K.M., Stopfer L., Marinkovic A., Vrbanac V., et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2015, 308(4):L344-L357.
124. Dingal P.C., Bradshaw A.M., Cho S., Raab M., Buxboim A., Swift J., et al. Fractal heterogeneity in minimal matrix models of scars modulates stiff-niche stem-cell responses via nuclear exit of a mechanorepressor. Nat. Mater. 2015.
125. Zhao H., Li X., Zhao S., Zeng Y., Zhao L., Ding H., et al. Microengineered in vitro model of cardiac fibrosis through modulating myofibroblast mechanotransduction. Biofabrication 2014, 6(4):045009.
126. Kloxin A.M., Benton J.A., Anseth K.S. In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 2010, 31(1):1-8.
127. Wang H., Haeger S.M., Kloxin A.M., Leinwand L.A., Anseth K.S. Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One 2012, 7(7):e39969.
128. Solon J., Levental I., Sengupta K., Georges P.C., Janmey P.A. Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys. J. 2007, 93(12):4453-4461.
129. Prager-Khoutorsky M., Lichtenstein A., Krishnan R., Rajendran K., Mayo A., Kam Z., et al. Fibroblast polarization is a matrix-rigidity-dependent process controlled by focal adhesion mechanosensing. Nat. Cell Biol. 2011, 13(12). (1457-U1178).
130. Brown T.D. Techniques for mechanical stimulation of cells in vitro: a review. J. Biomech. 2000, 33(1):3-14.
131. Balestrini J., Hinz B. The mechanical regulation of myofibroblasts; mechanically-guided matrix remodeling and prevention of fibrosis in regenerative medicine. Cells, Forces and the Microenvironment 2014, Pan Staford Publishing Pte Ltd, Singapore. A.E. Pelling, C.M. Cuerrier (Eds.).
132. Achterberg V.F., Buscemi L., Diekmann H., Smith-Clerc J., Schwengler H., Meister J.J., et al. The nano-scale mechanical properties of the extracellular matrix regulate dermal fibroblast function. J. Investig. Dermatol. 2014, 134(7):1862-1872.
133. Wang J., Chen H., Seth A., McCulloch C.A. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2003, 285(5):H1871-H1881.
134. Balestrini J.L., Billiar K.L. Magnitude and duration of stretch modulate fibroblast remodeling. J. Biomech. Eng. 2009, 131(5):051005.
135. Guo Y., Zeng Q.-c., Zhang C.-q., Zhang X.-z., Li R.-x., Wu J.-m., et al. Extracellular matrix of mechanically stretched cardiac fibroblasts improves viability and metabolic activity of ventricular cells. Int. J. Med. Sci. 2013, 10(13):1837-1845.
136. Blaauboer M.E., Smit T.H., Hanemaaijer R., Stoop R., Everts V. Cyclic mechanical stretch reduces myofibroblast differentiation of primary lung fibroblasts. Biochem. Biophys. Res. Commun. 2011, 404(1):23-27.
137. Gupta V., Grande-Allen K.J. Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc. Res. 2006, 72(3):375-383.
138. Husse B., Briest W., Homagk L., Isenberg G., Gekle M. Cyclical mechanical stretch modulates expression of collagen I and collagen III by PKC and tyrosine kinase in cardiac fibroblasts. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293(5):R1898-R1907.
139. Papakrivopoulou J., Lindahl G.E., Bishop J.E., Laurent G.J. Differential roles of extracellular signal-regulated kinase 1/2 and p38MAPK in mechanical load-induced procollagen α1(I) gene expression in cardiac fibroblasts. Cardiovasc. Res. 2004, 61(4):736-744.
140. Song J., Zhu Y., Li J., Liu J., Gao Y., Ha T., et al. Pellino1-mediated TGF-β1 synthesis contributes to mechanical stress induced cardiac fibroblast activation. J. Mol. Cell. Cardiol. 2015, 79:145-156.
141. Gould R.A., Chin K., Santisakultarm T.P., Dropkin A., Richards J.M., Schaffer C.B., et al. Cyclic strain anisotropy regulates valvular interstitial cell phenotype and tissue remodeling in 3D culture. Acta Biomater. 2012, 8(5):1710-1719.
142. Waxman A.S., Kornreich B.G., Gould R.A., Moïse N.S., Butcher J.T. Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture. J. Vet. Cardiol. 2012, 14(1):211-221.
143. Merryman W.D., Lukoff H.D., Long R.A., Engelmayr G.C., Hopkins R.A., Sacks M.S. Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc. Pathol. 2007, 16(5):268-276.
144. Galie P.A., Russell M.W., Westfall M.V., Stegemann J.P. Interstitial fluid flow and cyclic strain differentially regulate cardiac fibroblast activation via AT1R and TGF-β1. Exp. Cell Res. 2012, 318(1):75-84.
145. Poobalarahi F., Baicu C.F., Bradshaw A.D. Cardiac myofibroblasts differentiated in 3D culture exhibit distinct changes in collagen I production, processing, and matrix deposition. Am. J. Physiol. Heart Circ. Physiol. 2006, 291(6):H2924-H2932.
146. Petersen A., Joly P., Bergmann C., Korus G., Duda G.N. The impact of substrate stiffness and mechanical loading on fibroblast-induced scaffold remodeling. Tissue Eng. A 2012, 18(17-18):1804-1817.
147. Cui Y., Hameed F.M., Yang B., Lee K., Pan C.Q., Park S., et al. Cyclic stretching of soft substrates induces spreading and growth. Nat. Commun. 2015, 6:6333.
148. Throm Quinlan A.M., Sierad L.N., Capulli A.A.K., Firstenberg L.E., Billiar K.L. Combining dynamic stretch and tunable stiffness to probe cell mechanobiology in vitro. PLoS One 2011, 6(8):e23272.
149. Chaudhuri O., Gu L., Darnell M., Klumpers D., Bencherif S.A., Weaver J.C., et al. Substrate stress relaxation regulates cell spreading. Nat. Commun. 2015, 6:6365.
150. Stroud J.D., Baicu C.F., Barnes M.A., Spinale F.G., Zile M.R. Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment. Am. J. Physiol. Heart Circ. Physiol. 2002, 282(6):H2324-H2335.
151. Zhao X.H., Laschinger C., Arora P., Szaszi K., Kapus A., McCulloch C.A. Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J. Cell Sci. 2007, 120(Pt 10):1801-1809.
152. Follonier Castella L., Buscemi L., Godbout C., Meister J.J., Hinz B. A new lock-step mechanism of matrix remodelling based on subcellular contractile events. J. Cell Sci. 2010, 123:1751-1760.
153. Follonier Castella L., Gabbiani G., McCulloch C.A., Hinz B. Regulation of myofibroblast activities: calcium pulls some strings behind the scene. Exp. Cell Res. 2010, 316(15):2390-2401.
154. Godbout C., Follonier Castella L., Smith E.A., Talele N., Chow M.L., Garonna A., et al. The mechanical environment modulates intracellular calcium oscillation activities of myofibroblasts. PLoS One 2013, 8(5):e64560.
155. Hinz B. The extracellular matrix and transforming growth factor-beta1: tale of a strained relationship. Matrix Biol. 2015.
156. Discher D., Dong C., Fredberg J.J., Guilak F., Ingber D., Janmey P., et al. Biomechanics: cell research and applications for the next decade. Ann. Biomed. Eng. 2009, 37(5):847-859.
157. Chiquet M., Gelman L., Lutz R., Maier S. From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim. Biophys. Acta 2009, 1793(5):911-920.
158. Shafieyan Y., Tiedemann K., Komarova S.V., Quinn T.M. Effects of low frequency cyclic mechanical stretching on osteoclastogenesis. J. Biomech. 2014, 47(15):3750-3757.
159. Luo T., Mohan K., Iglesias P.A., Robinson D.N. Molecular mechanisms of cellular mechanosensing. Nat. Mater. 2013, 12(11):1064-1071.
160. Discher D.E., Janmey P., Wang Y.L. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310(5751):1139-1143.
161. Geiger B., Spatz J.P., Bershadsky A.D. Environmental sensing through focal adhesions. Nat. Rev. Mol. Cell Biol. 2009, 10(1):21-33.
162. Rustad K.C., Wong V.W., Gurtner G.C. The role of focal adhesion complexes in fibroblast mechanotransduction during scar formation. Differentiation 2013, 86(3):87-91.
163. Moore S.W., Roca-Cusachs P., Sheetz M.P. Stretchy proteins on stretchy substrates: the important elements of integrin-mediated rigidity sensing. Dev. Cell 2010, 19(2):194-206.
164. Manso A.M., Kang S.M., Ross R.S. Integrins, focal adhesions, and cardiac fibroblasts. J. Investig. Med. 2009, 57(8):856-860.
165. Ross R.S., Borg T.K. Integrins and the myocardium. Circ. Res. 2001, 88(11):1112-1119.
166. Hinz B., McCulloch C.M. Integrin function in heart fibrosis: mechanical strain, TGF-β1 activation and collagen glycation. Extracellular Matrix: Pathobiology and Signalling 2012, 407-431. DeGruyter, Berlin, Germany. N. Karamanos (Ed.).
167. Carraher C.L., Schwarzbauer J.E. Regulation of matrix assembly through rigidity-dependent fibronectin conformational changes. J. Biol. Chem. 2013, 288(21):14805-14814.
168. Vogel V., Sheetz M. Local force and geometry sensing regulate cell functions. Nat. Rev. Mol. Cell Biol. 2006, 7(4):265-275.
169. Hinz B. It has to be the alphav: myofibroblast integrins activate latent TGF-beta1. Nat. Med. 2013, 19(12):1567-1568.
170. Henderson N.C., Sheppard D. Integrin-mediated regulation of TGFbeta in fibrosis. Biochim. Biophys. Acta 2013, 1832(7):891-896.
171. Kobayashi T., Sokabe M. Sensing substrate rigidity by mechanosensitive ion channels with stress fibers and focal adhesions. Curr. Opin. Cell Biol. 2010, 22(5):669-676.
172. Kuipers A.J., Middelbeek J., van Leeuwen F.N. Mechanoregulation of cytoskeletal dynamics by TRP channels. Eur. J. Cell Biol. 2012, 91(11-12):834-846.
173. Rahaman S.O., Grove L.M., Paruchuri S., Southern B.D., Abraham S., Niese K.A., et al. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J. Clin. Invest. 2014, 124(12):5225-5238.
174. Song Y., Zhan L., Yu M., Huang C., Meng X., Ma T., et al. TRPV4 channel inhibits TGF-beta1-induced proliferation of hepatic stellate cells. PLoS One 2014, 9(7):e101179.
175. Hatano N., Itoh Y., Muraki K. Cardiac fibroblasts have functional TRPV4 activated by 4α-phorbol 12,13-didecanoate. Life Sci. 2009, 85(23-26):808-814.
176. Adapala R.K., Thoppil R.J., Luther D.J., Paruchuri S., Meszaros J.G., Chilian W.M., et al. TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J. Mol. Cell. Cardiol. 2013, 54:45-52.
177. Xie J., Zhang Q., Zhu T., Zhang Y., Liu B., Xu J., et al. Substrate stiffness-regulated matrix metalloproteinase output in myocardial cells and cardiac fibroblasts: implications for myocardial fibrosis. Acta Biomater. 2014, 10(6):2463-2472.
178. Ni J., Dong Z., Han W., Kondrikov D., Su Y. The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis. Free Radic. Biol. Med. 2013, 61:26-39.
179. Li Q., Xu Y., Li X., Guo Y., Liu G. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-beta1-TAK1. Toxicol. Lett. 2012, 211(2):91-97.
180. Bei Y., Hua-Huy T., Duong-Quy S., Nguyen V.H., Chen W., Nicco C., et al. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation. Pulm. Pharmacol. Ther. 2013, 26(6):635-643.
181. Knipe R.S., Tager A.M., Liao J.K. The rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol. Rev. 2015, 67(1):103-117.
182. Zhou Y., Huang X., Hecker L., Kurundkar D., Kurundkar A., Liu H., et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J. Clin. Invest. 2013, 123(3):1096-1108.
183. Hinz B., Gabbiani G., Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J. Cell Biol. 2002, 157(4):657-663.
184. Clement S., Hinz B., Dugina V., Gabbiani G., Chaponnier C. The N-terminal Ac-EEED sequence plays a role in [alpha]-smooth-muscle actin incorporation into stress fibers. J. Cell Sci. 2005, 118(Pt 7):1395-1404.
185. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., et al. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474(7350):179-183.
186. Halder G., Dupont S., Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 2012, 13(9):591-600.
187. Calvo F., Ege N., Grande-Garcia A., Hooper S., Jenkins R.P., Chaudhry S.I., et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 2013, 15(6):637-646.
188. Speight P., Nakano H., Kelley T.J., Hinz B., Kapus A. Differential topical susceptibility to TGFbeta in intact and injured regions of the epithelium: key role in myofibroblast transition. Mol. Biol. Cell 2013, 24(21):3326-3336.
189. Piersma B., de Rond S., Werker P.M., Boo S., Hinz B., van Beuge M.M., et al. YAP1 is a driver of myofibroblast differentiation in normal and diseased fibroblasts. Am. J. Pathol. 2015.
190. Crider B.J., Risinger G.M., Haaksma C.J., Howard E.W., Tomasek J.J. Myocardin-related transcription factors a and B are key regulators of TGF-beta1-induced fibroblast to myofibroblast differentiation. J. Investig. Dermatol. 2011, 131(12):2378-2385.
191. Scharenberg M.A., Pippenger B.E., Sack R., Zingg D., Ferralli J., Schenk S., et al. TGF-beta-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms. J. Cell Sci. 2014, 127(Pt 5):1079-1091.
192. Small E.M., Thatcher J.E., Sutherland L.B., Kinoshita H., Gerard R.D., Richardson J.A., et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ. Res. 2010, 107(2):294-304.
193. Luchsinger L.L., Patenaude C.A., Smith B.D., Layne M.D. Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts. J. Biol. Chem. 2011, 286(51):44116-44125.
194. O'Connor J.W., Riley P.N., Nalluri S.M., Ashar P.K., Gomez E.W. Matrix rigidity mediates TGFbeta1-induced epithelial-myofibroblast transition by controlling cytoskeletal organization and MRTF-A localization. J. Cell. Physiol. 2015, 230(8):1829-1839.
195. Yu-Wai-Man C., Treisman R., Bailly M., Khaw P.T. The role of the MRTF-A/SRF pathway in ocular fibrosis. Invest. Ophthalmol. Vis. Sci. 2014, 55(7):4560-4567.
196. Huang X., Yang N., Fiore V.F., Barker T.H., Sun Y., Morris S.W., et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am. J. Respir. Cell Mol. Biol. 2012, 47(3):340-348.
197. Shiwen X., Stratton R., Nikitorowicz-Buniak J., Ahmed-Abdi B., Ponticos M., Denton C., et al. A role of myocardin related transcription factor-A (MRTF-A) in scleroderma related fibrosis. PLoS One 2015, 10(5):e0126015.
198. Johnson L.A., Rodansky E.S., Haak A.J., Larsen S.D., Neubig R.R., Higgins P.D. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-beta-induced fibrogenesis in human colonic myofibroblasts. Inflamm. Bowel Dis. 2014, 20(1):154-165.
199. Sisson T.H., Ajayi I.O., Subbotina N., Dodi A.E., Rodansky E.S., Chibucos L.N., et al. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. Am. J. Pathol. 2015, 185(4):969-986.
200. Penke L.R., Huang S.K., White E.S., Peters-Golden M. Prostaglandin E2 inhibits alpha-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-a. J. Biol. Chem. 2014, 289(24):17151-17162.
201. Zilberberg L., Todorovic V., Dabovic B., Horiguchi M., Courousse T., Sakai L.Y., et al. Specificity of latent TGF-beta binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin. J. Cell. Physiol. 2012, 227(12):3828-3836.
202. Jenkins G. The role of proteases in transforming growth factor-beta activation. Int. J. Biochem. Cell Biol. 2008, 40(6-7):1068-1078.
203. Robertson I.B., Rifkin D.B. Unchaining the beast; insights from structural and evolutionary studies on TGFbeta secretion, sequestration, and activation. Cytokine Growth Factor Rev. 2013, 24(4):355-372.
204. Worthington J.J., Klementowicz J.E., Travis M.A. TGFbeta: a sleeping giant awoken by integrins. Trends Biochem. Sci. 2011, 36(1):47-54.
205. Frangogiannis N.G. Matricellular proteins in cardiac adaptation and disease. Physiol. Rev. 2012, 92(2):635-688.
206. Sarrazy V., Koehler A., Chow M.L., Zimina E., Li C.X., Kato H., et al. Integrins alphavbeta5 and alphavbeta3 promote latent TGF-beta1 activation by human cardiac fibroblast contraction. Cardiovasc. Res. 2014, 102(3):407-417.
207. Wipff P.J., Rifkin D.B., Meister J.J., Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 2007, 179(6):1311-1323.
208. Shi M., Zhu J., Wang R., Chen X., Mi L., Walz T., et al. Latent TGF-beta structure and activation. Nature 2011, 474(7351):343-349.
209. Buscemi L., Ramonet D., Klingberg F., Formey A., Smith-Clerc J., Meister J.J., et al. The single-molecule mechanics of the latent TGF-beta1 complex. Curr. Biol. 2011, 21:2046-2054.
210. Annes J.P., Chen Y., Munger J.S., Rifkin D.B. Integrin [alpha]V[beta]6-mediated activation of latent TGF-[beta] requires the latent TGF-[beta] binding protein-1. J. Cell Biol. 2004, 165(5):723-734.
211. Giacomini M.M., Travis M.A., Kudo M., Sheppard D. Epithelial cells utilize cortical actin/myosin to activate latent TGF-beta through integrin alpha(v)beta(6)-dependent physical force. Exp. Cell Res. 2012, 318(6):716-722.
212. Storm C., Pastore J.J., MacKintosh F.C., Lubensky T.C., Janmey P.A. Nonlinear elasticity in biological gels. Nature 2005, 435(7039):191-194.
213. MacQueen L., Sun Y., Simmons C.A. Mesenchymal stem cell mechanobiology and emerging experimental platforms. J. R. Soc. Interface 2013, 10(84):20130179.
214. Hinz B. Matrix mechanics and regulation of the fibroblast phenotype. Periodontol. 2013, 63(1):14-28.